Healthpeak Properties: The Market Still Underestimates Its Recovery Potential (NYSE:DOC)
· seekingalpha.com
Healthpeak Properties (DOC) stays a Buy: strong Q2, raised guidance, $1B asset sales, compelling valuation and dividend. Click here to read my analysis.
Back when I last covered Healthpeak Properties ( DOC ), I rated it a Buy, arguing how the valuation still offered room for upside despite its rally seen at that...